84bd90f5-4a1f-42a8-8eb1-5cb062a0b6ac.png
Biotechnology Market Anticipates Soaring to a Staggering USD 3,672.9 Billion by 2032 || Market.us
January 08, 2024 07:32 ET | Market.Us
New York, Jan. 08, 2024 (GLOBE NEWSWIRE) -- According to the market.us, the global Biotechnology market witnessed a valuation of USD 1023.8 Billion in 2022. Projections indicate a significant...
New Logo- Pls use this for all on going release.jpg
Green Star Products Issues a Force Majeure
January 05, 2022 09:30 ET | Green Star Products, Inc
SALT LAKE CITY, UT, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Today, Ms. Kristy Hunt President of Green Star Products, Inc. (US OTC: GSPI), stated that on December 28, 2021, Green Star Products issued a...
Shineco New Logo.png
Shineco, Inc. Announces Entering Into a Securities Purchase Agreement with GHS Investments, LLC with Gross Proceeds of $2.0 Million USD
December 06, 2021 16:15 ET | Shineco, Inc.
BEIJING, Dec. 06, 2021 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer and distributor of Chinese herbal medicines, organic agricultural and other biotech...
GSPI logo.jpg
Green Star Products: Ready to Close COVID-19 Contract at Shareholders Meeting
February 26, 2021 06:30 ET | Green Star Products, Inc
SALT LAKE CITY, UT, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Today, Mr. Joseph LaStella, President of Green Star Products, Inc. (USOTC: GSPI) stated, “The Company has enough early votes to close the...
GSPI logo.jpg
Green Star Products Signs Covid-19 Distribution Contract
December 14, 2020 09:30 ET | Green Star Products, Inc
SALT LAKE CITY, UT, Dec. 14, 2020 (GLOBE NEWSWIRE) -- Last Friday, December 11, 2020, Joseph LaStella, President of Green Star Products, Inc. (OTC: GSPI) announced he signed a Distribution Contract...
energias.jpg
Global Marine Biotechnology Market to Witness a CAGR of 9.61% during 2018-2024
March 04, 2019 06:51 ET | Energias Market Research
NEW YORK, March 04, 2019 (GLOBE NEWSWIRE) -- The global marine biotechnology market is expected to grow significantly from USD 3,500.4 million in 2017 to USD 6,500.6 million in 2024, at a CAGR of...
Beleave Strengthens
Beleave Strengthens Advisory Board With Addition of Andrew Steane
May 03, 2016 10:54 ET | Beleave Inc.
TORONTO, May 03, 2016 (GLOBE NEWSWIRE) -- Beleave Inc. (CSE:BE) (“Beleave” or the “Company”) is pleased to announce that Andrew Steane will be added to the company’s Advisory Board. With over 20...
FEI Partners with Fi
FEI Partners with Five Pharmaceutical Companies, the Medical Research Council and the University of Cambridge to form Cryo-EM Research Consortium 
April 04, 2016 06:05 ET | FEI Company
HILLSBORO, Ore. and LONDON, April 04, 2016 (GLOBE NEWSWIRE) -- FEI (NASDAQ:FEIC) has partnered with five pharmaceutical companies: Astex Pharmaceuticals, AstraZeneca, GlaxoSmithKline, Heptares...